Effect of exosome biomarkers for diagnosis and prognosis of breast cancer patients.

about

MicroRNA-34 family in breast cancer: from research to therapeutic potential

P2860

Q58548157-CA4F8722-9DF2-4776-813E-8B86ABB1CEB6

P2860

Effect of exosome biomarkers for diagnosis and prognosis of breast cancer patients.

Item

http://www.wikidata.org/entity/Q47397566

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Effect of exosome biomarkers for diagnosis and prognosis of breast cancer patients.

@en

Effect of exosome biomarkers for diagnosis and prognosis of breast cancer patients.

@nl

type

Item

label

Effect of exosome biomarkers for diagnosis and prognosis of breast cancer patients.

@en

Effect of exosome biomarkers for diagnosis and prognosis of breast cancer patients.

@nl

prefLabel

Effect of exosome biomarkers for diagnosis and prognosis of breast cancer patients.

@en

Effect of exosome biomarkers for diagnosis and prognosis of breast cancer patients.

@nl

P1476

Effect of exosome biomarkers for diagnosis and prognosis of breast cancer patients.

@en

P2093

G Shao

http://www.w3.org/2001/XMLSchema#string

J Zhang

http://www.w3.org/2001/XMLSchema#string

Z Wang

http://www.w3.org/2001/XMLSchema#string

P2860

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration

Microenvironmental Heterogeneity Parallels Breast Cancer Progression: A Histology-Genomic Integration Analysis

Triple-Negative Breast Cancer

Endobronchial ultrasound-guided transbronchial needle aspiration for the diagnosis of intrathoracic lymphadenopathy in patients with extrathoracic malignancy: a multicenter study.

Comparison of the HER2, estrogen and progesterone receptor expression profile of primary tumor, metastases and circulating tumor cells in metastatic breast cancer patients.

CA153 in Breast Secretions as a Potential Molecular Marker for Diagnosing Breast Cancer: A Meta Analysis

Plasma Exosome Profiling of Cancer Patients by a Next Generation Systems Biology Approach.

Clinical application of a microfluidic chip for immunocapture and quantification of circulating exosomes to assist breast cancer diagnosis and molecular classification

Exosomes enriched in stemness/metastatic-related mRNAS promote oncogenic potential in breast cancer.

Tumour exosome integrins determine organotropic metastasis.

P2888

s12094-017-1805-0

P304

906-911

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

meta-analysis

P356

10.1007/S12094-017-1805-0

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-11-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29143228

http://www.w3.org/2001/XMLSchema#string

Effect of exosome biomarkers for diagnosis and prognosis of breast cancer patients.

about

P2860

P2860

Effect of exosome biomarkers for diagnosis and prognosis of breast cancer patients.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698